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Abstract
Aim: The aim of this prospective cohort study was to assess the effect of a pocket 
irrigator/evacuator device (IED) in the non-surgical treatment of peri-implantitis.
Material and Methods: In total 24 patients having 38 implants diagnosed with peri-
implantitis were included in this study. Peri-implant pockets were irrigated six times 
in three consecutive weeks. The primary outcome was bleeding on probing (BoP). 
Secondary outcome parameters included plaque index (Pl), suppuration on probing 
(SoP), probing pocket depth (PPD), marginal bone loss (MBL), presence and numbers 
of periodontal pathogens. Parameters were assessed at baseline and 3 months after 
the last treatment. Treatment pain perception was scored using the visual analog 
scale (VAS) after the first and last treatment.
Results: At 3 months, IED treatment revealed significant reduction of peri-implant 
BoP (71% [±20] vs 57% [±28] [P = .014]) and peri-implant plaque scores (10 [±14] to 
5 [±9] [P = .039] [T0 vs T3 respectively]). Significant reduction in mean peri-implant 
PPD from 4.92 mm (SD ± 1.28) to 4.66 mm (SD ± 1.35) (P = .041) was observed. In 
addition, a reduction in VAS pain score between the first and the last (6th) treatment 
was found (P = .039). No reduction in SoP (P = .088) was found. No changes in mean 
periodontal full mouth plaque, BOP, SOP and PPD levels, MBL and microbiological 
outcomes were found.
Conclusion: Beneficial clinical effects in terms of BoP, PPD and PI were found at 
3 months after IED treatment. However, the IED does not seem to effectively treat 
peri-implantitis in terms of disease resolution.
K E Y W O R D S
clinical trial, dental implants, microbiology, peri-implantitis, pocket irrigation
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1  | INTRODUC TION
Treatment of peri-implant inflammation, that is, peri-implantitis and 
peri-implant mucositis, is mainly focused on decontamination of 
the implant surface in order to create peri-implant health and pre-
vent peri-implant bone loss. Various non-surgical peri-implantitis 
treatment modalities, including different mechanical debridement 
methods (curettes, air polishing and/or ultrasonic), laser (Er;YAG) 
and/or photodynamic treatments or pharmaceutical therapies (ch-
lorhexidine, local or systemic antibiotics), have been described in 
the literature.1 Although studies show satisfying results regarding 
the treatment of peri-implant mucositis, incomplete resolution of 
disease in the treatment of peri-implantitis is seen in the majority 
of non-surgical studies.2,3 A screw-shaped implant design, an over 
contoured prosthetic design or pain during a treatment intervention 
may limit the effect of conventional mechanical treatment modali-
ties. The use of alternative therapies could therefore be advocated. 
Recently, a new pocket irrigator/evacuator device (IED), the Fluxion® 
(GumCareCompanion, Gum Irrigator BV), based on a high-frequency 
change in evacuation and irrigation, has been introduced in a study by 
van Dijk et al4 to improve flushing of the subgingival area. Decreased 
probing pocket depths and reduced signs of inflammation (bleeding/
suppuration) 3 months after treatment 4 were found in their study 
on the treatment of periodontal pockets, using this IED in two treat-
ment sessions per week during a 3-week period. Whether the IED 
can be used as an effective device in the treatment of peri-implant 
diseases is yet unknown. Therefore, the aim of this prospective co-
hort study was to evaluate the clinical, microbial and radiographi-
cal effects of non-surgical peri-implantitis treatment using the IED. 
The null hypothesis formulated was that the use of the IED in the 
treatment of peri-implantitis has no effect on clinical, microbial and 
radiographical outcomes.
2  | METHODOLOGY AND STUDY 
POPUL ATION
2.1 | Methodology
Patients participating in this study were recruited from patient 
populations of the Center of Dentistry and Oral Hygiene and the 
Department of Oral and Maxillofacial Surgery of the University 
Medical Center Groningen (UMCG), Groningen, The Netherlands. 
Patients who were referred to one of these departments by exter-
nal dentists were also screened for participation. The study was 
conducted in full accordance with the principles of the Declaration 
of Helsinki as stated in 64th WMA General Assembly, Fortaleza, 
Brazil, October 2013 and in accordance with the Medical Research 
Involving Human Subjects Act (WMO). Approval by the Institutional 
Review Board of the University Medical Center Groningen, the 
Netherlands (METc2017.644) was given. A written informed con-
sent was obtained from all participants before entering the trial.
2.1.1 | Inclusion criteria
Patients who met the following criteria were found eligible to par-
ticipate in this study:
• Age ≥ 18 years;
• At least one endosseous implant in the oral cavity with clinical 
and radiographical signs of peri-implantitis, which was defined as: 
progressive marginal bone loss (MBL) of ≥2 mm, as compared to 
the initial bone level after implant placement, in combination with 
a peri-implant probing pocket depth (PPD) ≥5 mm and bleeding 
and/or suppuration on probing (SoP);
• Implants had been in function for at least two years;
• Good understanding of the treatment protocol and able to give 
informed consent.
2.1.2 | Exclusion criteria
A patient was excluded from participation in this study if any of the 
following criteria was met:
• Medical and general contraindications for the procedures;
• A history of local radiotherapy to the head and neck region;
• Uncontrolled diabetes (HbA1c > 7% or > 53 mmol/mol)5;
• Use of antibiotics during the last 3 months;
• Long-term use of anti-inflammatory drugs;
• Smoking
• Active periodontitis of the remaining dentition (PPD > 5 mm);
• Incapability of performing basic oral hygiene measures as a result 
of physical or mental disorders;
• Implants with bone loss exceeding 2/3 of the length of the 
implant;
• Implant mobility;
• Implants at which no pocket probing measurements could be per-
formed that is, no probing site could be identified
• Mechanical peri-implantitis treatment in the previous 3 months.
2.1.3 | Sample size determination
Since no data were available for estimating the effect size, a pilot 
study design was chosen. In total, 24 patients were included.6
2.2 | Study population
The guideline for reporting an observational study was followed as 
suggested by The Strengthening the Reporting of Observational 
Studies in Epidemiology (STROBE) Statement (guideline found 
online at http://www.equat or-netwo rk.org/repor ting-guide lines/ 
strob e/).
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2.2.1 | Study product
A detailed product description of the IED (the Fluxion®; 
GumCareCompanion, Gum Irrigator BV) is given by van Dijk et al.4 
Briefly, the apparatus consists of a base-station and a connected 
hand piece (see Figure 1). The hand piece contains a disposable noz-
zle (suction cup) with an internal hose and on/off button in the mid-
dle of the hand piece which (de)activates a vacuum pump. Through 
the nozzle hose, an alternated interplay between water flushing 
(high repeated frequency of 250 milliseconds per cycle) and evacua-
tion (negative pressure of 0.35 mm Hg) supposedly ensures irrigation 
after placement of the suction cup on the approximal/interdental 
area/papilla (see Figure 2).
2.2.2 | Study design and setting
The study was performed between June 2018 and March 2019 at 
the department of Oral and Maxillofacial surgery, at the University 
Medical Center Groningen (UMCG), The Netherlands. Peri-implant 
pockets were irrigated twice a week during a period of three con-
secutive weeks (six times in total).4 Two trained dental hygienists 
treated all sites with peri-implantitis sub- and supragingivally. During 
the first treatment appointment, the remaining dentition was cleaned 
using an ultrasonic device (EMS®) and if needed manually with perio-
dontal curettes (Gracey curettes; Hu-Friedy®). Patients received ex-
tensive oral hygiene instructions prior to submucosal irrigation using 
an electric toothbrush and interdental brushes and reinforcement 
took place every appointment. To ensure irrigation, care was taken 
to position the IED tip perpendicular to the implant axis. The sub-
mucosal sites with peri-implantitis were irrigated with water using 
the IED for 14 seconds (two intervals of 7 seconds; default setting 
IED) per site (four sites per implant, mesiobuccal, mesiolingual, dis-
tobuccal, distolingual). Clinical outcomes (bleeding on probing [BoP, 
%], plaque score [%], suppuration score [%], PPD [mm]), peri-apical 
radiographs and the presence and numbers of eight bacterial marker 
species were assessed at baseline (T0) and at 3 months (T3) after the 
last (6th) treatment. The patient-centred outcomes of treatment pain 
perception were evaluated using a Visual Analog Scale (VAS) (score 
0-10) immediately after the first and last (6th) treatment.
2.2.3 | Outcome measurements
Primary outcome parameter
The main study parameter was change in mean peri-implant bleeding 
score (%).
Secondary outcome parameters
Secondary outcome parameters were mean peri-implant plaque 
score (%), mean peri-implant SoP score (%) and mean peri-implant 
PPD. Other secondary parameters were mean full mouth periodon-
tal bleeding score, mean full mouth periodontal plaque score (%), 
mean full mouth periodontal suppuration score (%), mean periodon-
tal PPD, marginal soft tissue level at the midbuccal implant site (re-
cession), width of keratinized epithelium at the buccal implant site, 
mean peri-implant MBL, microbiological composition of the peri-
implant and periodontal area, complications and adverse events, and 
patient-reported pain outcome. A successful treatment outcome 
was defined as: peri-implant PPD < 5 mm, BoP ≤ 20% (maximum 
of one out of six sites bleeding) and no progressive bone loss at T3 
compared to T0.
2.2.4 | Clinical measurements
Full mouth periodontal and peri-implant chart
A full mouth periodontal and peri-implant chart were made prior 
to initial peri-implant and periodontal treatment and at T3 by one 
and the same examiner (DFMH). At six sites per tooth and implant 
(mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual, dis-
tolingual), BoP, presence of plaque (Pl), SoP, and PPD were assessed 
F I G U R E  1   The Fluxion
F I G U R E  2   Placement of the suction cup on the approximal/
interdental area/papilla
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(1 = present, 0 = not present for BoP, SoP and presence of plaque; 
absolute values measured to the nearest millimetre, using a Hu-
Friedy® PCPUNC156 periodontal probe for PPD). If the profile of 
the implant and/or the contour of the prosthesis hindered probing 
at six sites per implant, at least one position was identified where 
proper probing measurements could be performed. To assess the 
marginal soft tissue level, a partial Vinyl Polysiloxane (VPS) impres-
sion (EXABITE™ II NDS; GC America Inc) of the suprastructure was 
made at the implant site. This individual VPS mould was buccally 
trimmed to half way the suprastructure. The distance from the mid-
buccal marginal mucosa to the cervical margin of the VPS mould was 
assessed at the implant site at T0 and T3 (see Figure 3). In case of a 
solitary attachment (locator) or bar suprastructure present, the top 
of these suprastructures were taken as fixed reference point.
Radiographic analysis
Peri-apical radiographs were taken at baseline and 3 months after 
the last treatment (Planmeca Intra X-ray unit; Planmeca). An indi-
vidualized X-ray holder and paralleling technique were used to 
standardize radiographs and assure perpendicularity (ie position-
ing of the film parallel to the long axis of the implant).7 Peri-implant 
bone loss was measured on peri-apical radiographs taken at base-
line and 3 months after the last treatment using DICOM software 
(DicomWorks 1.5). Calibration of each radiograph took place on a 
3-point reference scale using the known implant length or diameter 
(see Figure 4). Bone level difference was calculated at the mesial 
and distal implant site. Radiographic examination of 10 randomly 
selected implants was done twice by DFMH and HJAM in order to 
calculate the inter-observer agreement.
Microbiological sampling
The microflora residing in the peri-implant sulcus was sampled at T0 
and T3 using four sterile paper points. Samples were taken at four 
sites around the implant (mesiobuccal, distobuccal, mesiolingual 
and distolingual). In patients with more than one implant included, 
sampling was divided over the implants and the collected samples 
were pooled in an empty vial. In dentate patients, bacterial samples 
were also taken from the deepest tooth site in each quadrant. If no 
deepened pockets were present, samples were taken from the me-
siobuccal pockets of the 16, 26, 36 and 46. Outcome variables were 
presence and numbers of Aggregatibacter actinomycetemcomitans 
(Aa), Porphyromonas gingivalis (Pg), Prevotella intermedia (Pi), Tannerella 
forsythia (Tf), Fusobacterium nucleatum (Fn), Parvimonas micra (Pm), 
Treponema denticola (Td) and Filifactor alocis (Fa). Microbial samples 
were sent to Laboral Diagnostics, Houten, the Netherlands and ana-
lysed using quantitative polymerase chain reaction (qPCR) technique.
Other study parameters
History of periodontitis, alcohol use, implant function time, implant 
type and implant surface topography, medical condition and medica-
tion intake were other study parameters assessed.
F I G U R E  3   Measurement of distance from mid-buccal marginal 
mucosa to Vinyl Polysiloxane (VPS) mold F I G U R E  4   DICOM measurement of mesial and distal marginal 
bone loss
     |  5HENTENAAR ET Al.
2.2.5 | Statistical analysis
The primary and secondary clinical outcome variables were analysed at 
patient level. Variables were assessed at implant/tooth-level by com-
puting the mean value of the 6 scores per implant and tooth per param-
eter, at T0 and T3. Outcomes in patients having more than one implant 
were combined. A Wilcoxon signed-rank test (given the non-normal 
distributed data) was used to analyse for within-patient differences be-
tween baseline and follow-up (3 months) for the periodontal and peri-
implant clinical parameters PI and SoP, microbiological outcomes and 
patient-centred outcomes (VAS score 0-10). A paired sampled t test 
(given the normal distributed data) was used to analyse the difference 
in mean periodontal and peri-implant BoP, PPD and MBL between T0 
and T3. A Cohen's kappa was calculated for the inter-observer agree-
ment of peri-apical radiograph analysis. For all other study parameters, 
quantitative descriptive analysis was performed. Statistical Package 
for the Social Sciences (SPSS Statistics for Windows, IBM, Version 23.0 
Armonk, NY, US) was used for all analyses.
3  | RESULTS
In total, 24 adult patients with 73 implants of which 38 implants di-
agnosed with peri-implantitis were included in the study. No patients 
were lost to follow-up, and no implants were lost. No peri-implant 
MBL occurred, and no mobility of implants was detected during or at 
completion of the study. An overview of the patient and implant char-
acteristics is presented in Table 1 and 2. Outcomes on clinical param-
eters PI and SOP showed a non-normal distribution and are therefore 
presented with median values and corresponding interquartile range 
(IQR) and p-values (see Table 3 and 4). The means of BoP and PPD are 
presented with corresponding standard deviation (SD).
3.1 | Primary outcome
A reduction in mean peri-implant BoP between T0 and T3 (71% 
[±20]; 57% [±28], respectively) was found (P = .014) (see Table 3).
3.2 | Secondary outcomes
At the three-month evaluation, the mean peri-implant plaque scores 
had dropped from 10 (±14) to 5 (±9) (P = .039), and the peri-implant 
SoP reduced from a median of 31 [IQR; 0, 50] at T0 to a median of 
12 [IQR; 0, 28] at T3 (P = .088) (see Table 3). A reduction in mean 
peri-implant PPD was found between T0 (4.92 [SD ± 1.28]) and T3 
(4.66 [SD ± 1.35]) (P = .041). No differences in mean periodontal full 
mouth clinical parameters were found between T0 and T3 (Table 4). No 
complications occurred and no adverse events were recorded during 
the study. Pain scores of 0.41 ± 0.91 (VAS pain score scale 0-10) and 
0.05 ± 0.21 were found after the first treatment and the last (6th) treat-
ment, respectively (P = .039). A sub-analysis for mean pocket depth 
initially measuring: <4 mm, 4-5 mm, ≥5 mm is presented in Table 5.
3.2.1 | Peri-implant bone loss
A correlation coefficient for the inter-observer agreement for MBL 
measurements was calculated (Cronbach's a). An agreement of 
α = 0.989 was found. No difference in mean peri-implant bone loss 
between T0 and T3 (3.67 mm (SD ± 1.93) vs 3.64 mm (SD ± 2.02) 
respectively) was observed (P = .558).
3.2.2 | Microbiological outcomes
A total of 46 submucosal samples (23 patients with one peri-implant 
sample and one periodontal sample) were available for microbio-
logical analysis. One microbiological patient sample got lost in mail 
transport. Peri-implant microbiological outcomes did not show a 
significant difference between T0 and T3 (see Table 6). High detec-
tion frequencies were found at implant sites for Tf, Pm, Fn (found in 
respectively 20, 22 and 23 patients). The lowest frequencies were 
TA B L E  1   Characteristics of included patients
Characteristics N
Total number of patients 24
Age (y; mean [SD]) 60 (12.51)
Gender; M (male), F (female) M 11, F 13
Smoking
n subjects at baseline (%) 0 (0%)
n subjects at 3 mo (%) 3 (13%)
History of periodontitis; n subjects (%) 6 (25%)
Dental status; n subjects (%)
Partially edentulous 22 (92%)
Fully edentulous 2 (8%)
Medication intake; n subjects (%) 13 (54%)
≥3 medicines, n of total subjects taking 
medication (%)
6 (46%)
<3 medicines, n of total subjects taking 
medication (%)
7 (54%)
Alcohol usera ; n subjects (%) 6 (25%)
Mean marginal bone level (T0; T3) 3.67 mm; 3.64 mm
Mean recessionb  (T0; T3) 7.91 mm; 8.03 mm
Mean VAS score (after 1st, after 6th 
treatment)
0.41; 0.05
Deepest pocket per implant at baseline; n implants (%)
5 mm 5 (13%)
6 mm 12 (32%)
7 mm 13 (34%)
≥8 mm 8 (21%)
Treatment success; n subjects (%) 5 (21%)
meanPPD (T0; T3) 3.89 mm; 3.13 mm
MBLc  (T0; T3) 2.78 mm; 2.75 mm
aPatients were considered alcohol users if their daily intake exceeded 
10 g; equivalent to a quarter litre of beer (5%).31 
bDistance from the midbuccal marginal mucosa to the cervical margin of 
the individualized VPS mould. 
cMarginal bone loss at implant level. 
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found for Aa, Pi and Td which were found in 3, 6 and 8 patients at 
baseline, respectively. No significant difference between T0 and T3 
for periodontal microbiological outcome was found.
3.2.3 | Success outcome
Five patients (21%) having seven implants (18%) were treated suc-
cessfully (PPDs < 5 mm, BoP ≤ 20%, no progressive bone loss). 
Probing pocket depths corresponding with the successfully treated 
patients are presented in Table 1. A difference of 0.76 mm was found 
between baseline and 3 months after treatment.
4  | DISCUSSION
4.1 | Principal findings
The aim of this prospective cohort study was to evaluate the clini-
cal and microbial effects of non-surgical peri-implantitis treatment 
using an IED. Statistically significant reductions were found for 
the primary outcome BoP and secondary outcomes Pl and PPD at 
3 months after the last (6th) IED treatment. In addition, a signifi-
cant treatment pain reduction between pain outcomes scored dur-
ing the first and last (6th) treatment appointment was observed. 
No significant differences were found regarding the secondary 
peri-implant clinical parameters: SoP, marginal bone level, micro-
biological load or any of the mean periodontal full mouth levels. 
Therefore, the formulated null hypothesis of no effect could be 
partly rejected.
4.2 | Comparison with current literature
A direct comparison of the results with the current literature is not 
possible since no other studies on peri-implantitis with repeated 
peri-implant treatment sessions in consecutive weeks have been de-
scribed in the literature. A split mouth study by van Dijk et al 2018 on 
inflamed periodontal sites is the single study that describes the results 
TA B L E  2   Included implants characteristics and prosthetic 
factors
Characteristics N
Total number of implants (range) 73 (1-9)
Number of implants with peri-implantitis 
(range)
38 (1-5)
Implant brand, implant surface; n implants (%)
Nobel Biocare
Porous anoidized surface, TiUnite® 21 (55%)
Straumann




Fluoride-treated TiOBlast, Osseospeed® 5 (13%)
Biomet 3i




Sandblasted acid-etched, Promote® 2 (5%)
IMZ
Titanium plasma sprayed 1 (3%)
Implant function time (years; mean [range]) 9 (2.2;17.6)
Implant position; n implants (%)
Maxilla 29 (76%)
Mandibula 9 (24%)
Implant restoration; n implants (%)
Screw-retained 24 (63%)
Cement-retained 14 (22%)
Splinted/non-splinted; n implants (%) 18 (47%)/20 (53%)
Parameters





[IQR] Mean (SD) Mean (SD)
BoP (%)b  — — 71 (±20) 57 (±28) .014**,b
PI (%)c  0 [0,17] 0 [0,8] 10 (±14) a  5 (±9)a  .039*,a
SoP (%)c  31 [0,50] 12 [0,28] — — .088
PPD (mm)b  — — 4.92 (±1.28) 4.66 (±1.35) .041**,b
Abbreviations: BoP, peri-implantitis bleeding on probing; IQR, Interquartile Range; Pl, peri-
implantitis plaque score; PPD, probing pocket depth; SD, standard deviation; SoP, peri-implantitis 
suppuration on probing.
aMean values of PI are presented to improve understanding of the significant median reduction. 
bPaired sampled t test for T0 vs T3. 
cWilcoxon signed-rank test for T0 vs T3. 
*Statistically significant difference between median levels at baseline and 3 mo after the last (6th) 
treatment (P < .05, power 95%). 
**Statistically significant difference between mean levels at baseline and 3 mo after the last (6th) 
treatment (P < .05, power 95%). 
TA B L E  3   Overview of median and 
mean peri-implant clinical parameters 
at baseline (T0) and 3 mo after (T3) 
treatment
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of repeated use of an IED in consecutive weeks.4 Outcomes of the pre-
sent study seem in line with the study by van Dijk et al 2018, showing a 
significant reduction in BoP, PPD and PI after IED treatment. However, 
compared to the incremental PPD difference and mean BoP and PI 
reduction described in the study by van Dijk et al 2018, smaller dif-
ferences in outcomes of those parameters were found in the present 
Parameters






[IQR] Mean (SD) Mean (SD)
BoP (%)a — — 14 (±9) 13 (±13) .676
PI (%)b 18 [8,43] 14 [7,29] — — .322
SoP (%)b 0 [0,0] 0 [0,0] — — 1.000
PPD (mm)a — — 1.94 (±0.67) 1.97 (±0.68) .547
Abbreviations: BoP, full mouth periodontal bleeding on probing; IQR, Interquartile Range; Pl, full 
mouth periodontal plaque score; PPD, full mouth periodontal probing pocket depth; SD, standard 
deviation; SoP, full mouth periodontal suppuration on probing.
aPaired sampled t test for T0 vs T3. 
bWilcoxon signed-rank test for T0 vs T3. 
TA B L E  4   Overview of median and 
mean periodontal full mouth clinical 
parameters at baseline (T0) and 3 mo after 
(T3) treatment
T0 T3 ∆T0-T3
Mean probing pocket depth 4.92 [2.46; 8.17] 4.66 [2.33; 7.67] 0.26 [−0.13; −0.50]
n implants (number of sites) 38 (228)
Mean probing pocket 
depth < 4 mm
3.26 [2.46; 3.83] 3.00 [2.33; 4.00] 0.26 [−0.13; 0.17]
P-valuea  P = .541
n implants (number of sites)
5 (30)
Mean probing pocket depth 
4-5 mm
4.38 [4.00; 4.83] 4.17 [ 3.75; 5.33] 0.21 [−0.25; 0.50]
P-valuea  P = .071
n implants (number of sites)
20 (120)
Mean probing pocket 
depth ≥ 5 mm
6.12 [5.30; 8.17] 5.82 [3.83; 7.67] 0.30 [−1.47; −0.50]
P-valuea  P = .228
n implants (number of sites)
13 (78)
aStatistical analysis between T0 and T3. 
TA B L E  5   Subdivided mean peri-
implant probing pocket depth and range 
[min-max] in mm with total number of 
implants (n)
TA B L E  6   Log-transformed median and mean peri-implant bacterial counts before (T0) and 3 mo after (T3) treatment, number of patients 
(n) with counts above detection level (DL) at T0 and T3
T0 T3 T0 T3 T0 T3
Median IQR Median IQR Mean SD Mean SD n > DL n > DL
Aa 0 0.00, 0.00 0 0.00, 0.00 0.57 ±1.53 0.56 ±1.58 3 3
Pg 0 0.00, 6.49 0 0.00, 6.42 2.71 ±3.23 2.93 ±3.16 10 11
Pi 0 0.00, 2.30 0 0.00, 2.45 1.13 ±2.04 1.12 ±2.08 6 6
Tf 5.04 3.40, 5.54 4.14 3.30, 5.63 4.27 ±1.95 4.14 ±1.95 20 20
Pm 3.87 3.20, 4.85 3.43 2.64, 5.04 3.72 ±1.39 3.43 ±1.95 22 20
Fn 4.76 4.34, 5.28 4.7 4.20, 5.43 4.7 ±0.88 4.7 ±0.87 23 23
Td 0 0.00, 4.04 0 0.00, 3.11 1.59 ±2.32 1.33 ±2.02 8 8
Fa 0 0.00, 4.90 0 0.00, 4.61 2.17 ±2.49 2.1 ±2.36 11 11
Note: Outcomes based on 23 patient samples; 1 patient without baseline sample excluded from analysis. No significant reduction between T0 and T3 
for any of the pathogens was found (Wilcoxon signed-rank test).
Abbreviations: Aa, Aggregatibacter actinomycetemcomitans; Fa, Filifactor alocis; Fn, Fusobacterium nucleatum; IQR, interquartile range; Pg, 
Porphyromonas gingivalis; Pi, Prevotella intermedia; Pm, Parvimonas micra; Td, Treponema denticola; Tf, Tannerella forsythia.
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study. This could be explained by the fact that decontamination of the 
implant surface is more challenging than decontamination of tooth sur-
faces due to differences in accessibility between the peri-implant and 
periodontal pocket.8 Exposure of the roughened implant surface and 
in more severe sites exposure of implant threads could impair surface 
decontamination. When using an IED, one could imagine that implant 
treads create resistance against the intended flush out of the subgingi-
val biofilm. A complete distortion of the attached biofilm might there-
fore be hindered, maintaining a contaminated peri-implant surface and 
ongoing peri-implant inflammation.
Despite some overall clinical improvements, only 18% of the 
treated implants in the present study obtained clinically healthy 
peri-implant tissues. The majority of patients (57%) still showed 
BoP after therapy, which might indicate ongoing disease progres-
sion. It should be kept in mind; however; there may also be other 
factors that influence the bleeding tendency of the peri-implant 
mucosa, such as implant position, gender and PPD.9 In general, 
peri-implant tissues seem more prone to BoP than periodontal tis-
sues.10,11 In addition, probing forces exceeding 0.25 N can cause 
traumatic bleeding12 making that we have to interpret BoP values 
with caution. Considering this, the outcomes of the present study, 
with regard to BoP, do not differ much from other non-surgical 
peri-implantitis “one time treatment” studies, showing final bleed-
ing scores of >50%.13 Studies on treatment modalities such as ultra-
sonic device, an air-abrasive device, the Vector® system or Er;YAG 
laser combined with chemotherapeutics or as single therapy, on the 
other hand, have shown larger reductions in BoP.14-20 To improve 
treatment success rates of the IED, adjunctive measures (eg chlor-
hexidine alone or in conjunction with systemic delivery of antibiot-
ics) seem to be indicated.21-25
Concerning PPD, a comparable PPD reduction (0.2 mm) was 
found in a study by Renvert et al 2009 when an ultrasonic scaler was 
used with three-month follow-up.18 In contrast, Karring et al 2005 
showed a slight increase in pocket depth (0.2 mm).17 Greater PPD 
reductions were observed in studies when mechanical therapies 
were combined with the use of local antibiotics (0.49 mm).26 In 
the present study, greater PPD reductions (0.76 mm) were found 
for the successfully treated patients (Table 1). These implants ap-
peared to have a mean lower PPD and a mean lower MBL at base-
line. Successful non-surgical peri-implantitis treatment outcomes 
might therefore depend on the mean PPD and mean MBL at base-
line. A sub-analysis on pocket probing depth categories in our 
study revealed the highest reduction (0.30 mm) in the subgroup 
with mean pocket depth ≥ 5 mm at baseline (Table 5). Presumably, 
penetration into deep pockets may be easier than into moderate 
pockets.27
A sub-analysis of smoking status on clinical parameters was also 
performed by the group of van Dijk et al 2018. The largest incremen-
tal difference in PPD was observed in non-smokers and no significant 
difference between the BOP scores of smokers and non-smokers 
was observed. Although all patients in the current study presented 
themselves as non-smokers on inclusion, three patients reported 
positive on active smoking at the 3-month evaluation. A sub-analysis 
of the data, taking into account these active smokers, did not influ-
ence clinical outcomes.
Despite the intense treatment protocol of six repeated treat-
ments in a period of 3 weeks, the results of the present study do not 
seem better than “one time treatment” studies. Although peri-im-
plant plaque levels appeared lower at T3 than T0 (change in inter-
quartile range, see Table 3), no difference in full mouth plaque index 
was found. It could be therefore questioned if the repeated treat-
ment approach provides a substantial benefit and further improves 
the level of self-care. Future research on consecutive treatment ap-
pointments should confirm this finding.
No significant reduction of any of the microbiological patho-
gens studied at the 3-month evaluation was found. This is com-
parable to other studies reporting on microbiological outcome 
after single debridement therapy.15,28 Even studies reporting on 
the adjunctive use of a topical antibiotic (minocycline) or antiseptic 
(chlorhexidine) did not observe significant differences in levels of 
bacterial species.29,30
To the best of our knowledge, this is the first study which eval-
uated how much pain patients experienced during non-surgical 
peri-implantitis therapy. Patients reported low levels of pain (0.41 
on VAS scale 0-10) during the first treatment and even lower lev-
els during the last treatment (6th) (0.05). It might be speculated that 
the lower levels of pain during the last treatment are linked to less 
inflamed peri-implant tissues but future studies should elucidate on 
this finding.
4.3 | Limitations of the study and future 
recommendations
The single arm study design, limited sample size and short follow-
up should be considered as drawbacks of our study. In addition, the 
influence of the IED on soft tissue damage, the true ability of sub-
gingival fluid penetration, the appropriate size of the suction tip and 
angulation of tip placement during treatment remain unclear. Future 
research on the IED should focus on the effect of treatment in incipi-
ent peri-implantitis lesions, peri-implant mucositis or in supportive 
peri-implant therapy, preferably combined with using an antiseptic 
solution as irrigating agent in a randomized clinical trial with longer 
follow-up.
4.4 | Conclusion
The IED does not effectively treat peri-implantitis in terms of dis-
ease resolution. However, some beneficial effects were found such 
as reduced BoP (%), reduced plaque score (%) and reduced PPD at 
3 months after treatment. The repeatedly applied therapy does not 
seem to result in significantly better treatment outcomes compared 
to the “one time treatment” outcomes found in the literature.
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5  | CLINIC AL RELE VANCE
5.1 | Scientific rationale for the study
The most effective approach to treat peri-implantitis remains to be 
found. Recently, a new pocket IED based on an alternated interplay 
between flushing and evacuation has been introduced.
5.2 | Principal findings
This prospective cohort study indicates that the IED does not seem 
to be suitable to treat peri-implantitis in terms of disease resolution, 
but some beneficial effects may be found such as reduced clinical 
parameters and reduced pain perception.
5.3 | Practical implications
Future research on the IED is needed, focussing on the effect of 
treatment in incipient peri-implantitis lesions, peri-implant mucositis 
or in supportive peri-implant therapy.
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